Study Title
An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Protocol ID
RG_17-427 (FaR-RMS)
Disease (Sub Disease)
Rhabdomyosarcoma
Diagnosis Stage
Relapsed/ refractory
Location
NSW, QLD, VIC, WA, NZ
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
University of Birmingham
University of Birmingham
Links
Trial Status
Open
Sites
Royal Children's Hospital
Peter MacCallum Cancer Centre
Christchurch Hospital
The Children's Hospital at Westmead
Perth Children's Hospital
Starship Hospital
Monash Children's Hospital
John Hunter Children's Hospital
Sydney Children's Hospital
Queensland Children's Hospital
Peter MacCallum Cancer Centre
Christchurch Hospital
The Children's Hospital at Westmead
Perth Children's Hospital
Starship Hospital
Monash Children's Hospital
John Hunter Children's Hospital
Sydney Children's Hospital
Queensland Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
no limits
International registry ID's
NCT04625907
| Study Title | An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma |
|---|---|
| Protocol ID | RG_17-427 (FaR-RMS) |
| Disease (Sub Disease) | Rhabdomyosarcoma |
| Diagnosis Stage | Relapsed/ refractory |
| Location | NSW / QLD / VIC / WA / NZ |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ University of Birmingham |
| Links | https://clinicaltrials.gov/ct2/show/NCT04625907 |
| Trial Status | Open |
| Trial Open Date | 17/09/2020 |
| Sites | Royal Children's Hospital / Peter MacCallum Cancer Centre/ Christchurch Hospital/ The Children's Hospital at Westmead/ Perth Children's Hospital/ Starship Hospital / Monash Children's Hospital/ John Hunter Children's Hospital/ Sydney Children's Hospital / Queensland Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 1 |
| Age Eligibility | no limits |
| International registry ID's | NCT04625907 |